{
  "data": {
    "indicator": {
      "slug": "share-of-clinical-development-medicines-dedicated-to-non-communicable-diseases",
      "name": "Share of clinical development medicines dedicated to non-communicable diseases",
      "definition": "Proportion of medicines in clinical development that target non-communicable diseases.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2025-01-01",
        "period_label": "2025",
        "value": 75,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGF1",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1",
        "source_org": "IFPMA",
        "source": {
          "org": "IFPMA",
          "org_short_name": "IFPMA",
          "document_title": "Enabling innovation: The R&D ecosystem for medicines and vaccines",
          "document_url": "https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/",
          "locator": "Enabling innovation: The R&D ecosystem for medicines and vaccines",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}